Enoblituzumab Biosimilar - Anti-CD276 Antibody - BSA and Azide free
Description du produit
Recombinant humanized monoclonal antibody to CD276.
Applications
ELISA, Flow Cytometry
Recommander des dilutions
Flow Cytometry: 1:100
Reactivité
Human
Hôte
Humanized
Clonalité
Monoclonal
Isotype
IgG1
Conjuguer
Unconjugated
Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Forme du produit
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Stockage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Notes générales
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
ELISA plate pre-coated by 2 µg/ml (100 µl/well) Recombinant Human CD276 Protein (Fc Chimera 6xHis Tag) (A318396) can bind Anti-CD276 Humanized Antibody [Enoblituzumab Biosimilar] - Azide free (A318946) in a linear range of 0.24-31.25 µg/ml.
HEK293 cell line transfected with irrelevant protein (B) and human B7-H3 (A) were surface stained with Anti-CD276 Humanized Antibody [Enoblituzumab Biosimilar] - Azide free (A318946) at 1 µg/ml followed by Anti-Human IgG Antibody (Alexa 488).
Produits alternatifs à Anti-CD276 Anticorps (A318946)